Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles |
| |
| Institution: | 1. Institute for Translational Vaccinology (InTraVacc), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands;2. Immunology of Infectious Diseases and Vaccines (IIV), National Institute of Public Health and the Environment, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands;3. Department of Internal Medicine, Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands;1. Sanofi Pasteur, Lyon, France;2. Department of Psychology, Kingston University, Kingston upon Thames, UK;1. Department of Life Science, Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongsangbuk-do 37673, South Korea;2. Department of Chemistry, Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, South Korea;1. Division of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan;2. Division of Bacteriology, National Institute of Cholera and Enteric Diseases, Kolkata, India;1. GSK Vaccines Institute for Global Health (GVGH) S.r.l. (former Novartis Vaccines Institute for Global Health, NVGH), Via Fiorentina 1, 53100 Siena, Italy;2. Dipartimento di Scienze della Vita, Ed. C11, Università degli Studi di Trieste, via L. Giorgieri 1, 34127 Trieste, Italy;3. Antimicrobial Discovery Center, Department of Biology, 360 Huntington Ave., Boston, MA 02115, United States;4. Jenner Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK;1. School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA;2. Department of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA |
| |
| Abstract: | Outer Membrane Vesicles (OMVs) are gaining attention as vaccine candidates. The successful expression of heterologous antigens in OMVs, with the OMV functioning both as adjuvant and delivery vehicle, has greatly enhanced their vaccine potential. Since there are indications that surface exposed antigens might induce a superior immune response, targeting of heterologous antigens to the OMV surface is of special interest. Several systems for surface display of heterologous antigens on OMVs have been developed. However, these systems have not been used to display lipidated membrane-associated proteins known as lipoproteins, which are emerging as key targets for protective immunity. We were therefore interested to see whether we could express a foreign lipoprotein on the outer surface of OMVs. When outer surface protein A (OspA), a borrelial surface-exposed lipoprotein, was expressed in meningococci, it was found that although OspA was present in OMVs, it was no longer surface-exposed. Therefore, a set of fusions of OspA to different regions of factor H binding protein (fHbp), a meningococcal surface-exposed lipoprotein, were designed and tested for their surface-exposure. An N-terminal part of fHbp was found to be necessary for the successful surface display of OspA on meningococcal OMVs. When mice were immunized with this set of OMVs, an OspA-specific antibody response was only elicited by OMVs with clearly surface-exposed OspA, strengthening the idea that the exact positioning of an antigen in the OMV affects the immune response. This method for the surface display of heterologous lipoproteins on OMVs is a step forward in the development of OMVs as a vaccine platform. |
| |
| Keywords: | OMV Outer Membrane Vesicles Surface display Heterologous expression Lipoprotein OspA fHbp |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
